ASN's Mission

To create a world without kidney diseases, the ASN Alliance for Kidney Health elevates care by educating and informing, driving breakthroughs and innovation, and advocating for policies that create transformative changes in kidney medicine throughout the world.

learn more

Contact ASN

1401 H St, NW, Ste 900, Washington, DC 20005

email@asn-online.org

202-640-4660

The Latest on X

Kidney Week

Abstract: FR-PO295

Mechanism of Disease Progression by Renin Overexpression in the db/db-UNx Model: A Proteomic Analysis

Session Information

Category: Diabetic Kidney Disease

  • 701 Diabetic Kidney Disease: Basic

Authors

  • Jagarlapudi, Srinath, Pfizer, Cambridge, MA, Cambridge, Massachusetts, United States
  • Keenan, Rose Ann, Pfizer, Cambridge, MA, Cambridge, Massachusetts, United States
  • Al-Harthy, Sabra D., Pfizer, Cambridge, MA, Cambridge, Massachusetts, United States
  • Romoli, Simone, Pfizer, Cambridge, MA, Cambridge, Massachusetts, United States
  • Halsey, Charles, Pfizer, Cambridge, MA, Cambridge, Massachusetts, United States
  • Culver, Jeffrey A., Pfizer, Cambridge, MA, Cambridge, Massachusetts, United States
  • Morin, Jeffrey, Pfizer, Cambridge, MA, Cambridge, Massachusetts, United States
  • Hirenallur-Shanthappa, Dinesh K., Pfizer, Cambridge, MA, Cambridge, Massachusetts, United States
  • Feliers, Denis, Pfizer, Cambridge, MA, Cambridge, Massachusetts, United States
Background

The db/db-UNx-renin model has gained in popularity, showing both increased albuminuria and reduced glomerular filtration rate (GFR). Our aim was to characterize the renal injury of db/db-UNx-renin mice using proteomics and to understand the role of renin overexpression in disease progression.

Methods

Four weeks-old db/db mice were subjected to uninephrectomy, two weeks later received an intravenous injection of an AAV containing either an empty vector or the human renin gene and the experiment was terminated at 16 weeks of age. Albuminuria was measured every two weeks, renal oxygen content and renal volume and transcutaneous GFR were determined at the end of the experiment. The remaining kidney was harvested, and proteomics analysis performed on the cortical fraction.

Results

Compared to db/m mice, GFR and renal oxygenation were increased in db/db-UNx mice, indicating a state of hyperfiltration. Renin overexpression caused a significant reduction in GFR in these mice. In db/db-UNx mice, albuminuria progressed throughout the experiment, while in db/db-UNx-renin mice, albuminuria peaked 2 weeks after AAV-renin injection and remained high. Renal hypertrophy was evident in db/db-UNx mice while cardiac hypertrophy was only observed in db/db-UNx-renin mice. Proteomics analysis of renal cortex showed that pathways associated with protein synthesis, energy metabolism, transport activity, mitochondria and respiration, adipogenesis and glycolysis and gluconeogenesis and amino acid metabolism were activated in db/db-UNx mice, suggesting a metabolic adaptation to the hyperfiltration seen in these mice. Renin overexpression, on the other hand, activated pathways associated with renal injury, extracellular matrix remodeling, inflammation, complement activation, macrophage activation, secretion of pro-angiogenic and pro-proliferative factors, and clot formation.

Conclusion

This study sheds light on the mechanism of kidney injury during diabetes and distinguishes two phases of the disease. In the hyperfiltrating phase, the renal tubules adapt by increasing their transport activity and energy production, while activation of complement, inflammation and coagulation pathways seem to play a role in the disease progression phase caused by renin overexpression.